Madeline St. Onge, MBA

Madeline is a business strategist at Dark Horse Consulting supporting clients across the cell and gene therapy sector via her deep expertise in market research and forecasting, competitive landscaping, diligence, and strategic planning. Her work focuses on helping companies evaluate market opportunities, assess competitive dynamics, and develop data-driven strategies to inform key business decisions.

‍

Prior to joining Dark Horse, Madeline worked at the International Society for Cell & Gene Therapy (ISCT), the global professional organization dedicated to advancing the clinical translation of cell and gene therapies. In this role, she led corporate sales and partnerships, including conference sponsorships and corporate memberships, while serving as a key interface between ISCT leadership and industry stakeholders. Through close engagement with senior executives across biotechnology, pharmaceutical, and enabling technology companies, she developed a strong understanding of the evolving cell and gene therapy landscape, including the commercial, regulatory, and operational challenges shaping the field.

‍

Earlier at ISCT, Madeline managed educational programming for the ISCT Annual Meetings, working with key opinion leaders to curate peer-reviewed programs focused on advances in cell and gene therapy research, development, and clinical translation.

‍

• Competitive landscape scans
• Due diligence
• Voice of customer studies
• Marketing support
• Quantitative modeling, such as market size and/or valuation modeling

International Society for Cell & Gene Therapy (ISCT)
Associate Director, Industry AffairsManager, Scientific and Industry Affairs

Schulich School of Business, York University
Master of Business Administration (MBA)

University of British Columbia
B.S. in Biology